Operating Income - Maat Pharma SA (PAR:MAAT) - Alpha Spread
M

Maat Pharma SA
PAR:MAAT

Watchlist Manager
Maat Pharma SA
PAR:MAAT
Watchlist
Price: 7.3 EUR 2.24% Market Closed
Market Cap: 101.4m EUR
Have any thoughts about
Maat Pharma SA?
Write Note

Maat Pharma SA
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Maat Pharma SA
Operating Income Peer Comparison

Comparables:
VLA
NANO
IPH
GNFT
ALERS

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
M
Maat Pharma SA
PAR:MAAT
Operating Income
-€19.9m
CAGR 3-Years
-56%
CAGR 5-Years
-35%
CAGR 10-Years
N/A
Valneva SE
PAR:VLA
Operating Income
-€136.2m
CAGR 3-Years
-5%
CAGR 5-Years
N/A
CAGR 10-Years
-19%
Nanobiotix SA
PAR:NANO
Operating Income
-€26.8m
CAGR 3-Years
10%
CAGR 5-Years
2%
CAGR 10-Years
-13%
Innate Pharma SA
PAR:IPH
Operating Income
-€38.6m
CAGR 3-Years
-58%
CAGR 5-Years
N/A
CAGR 10-Years
-15%
Genfit SA
NASDAQ:GNFT
Operating Income
-€26.7m
CAGR 3-Years
30%
CAGR 5-Years
17%
CAGR 10-Years
-10%
Eurobio Scientific SA
PAR:ALERS
Operating Income
€14.5m
CAGR 3-Years
-44%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Maat Pharma SA's Operating Income?
Operating Income
-19.9m EUR

Based on the financial report for Dec 31, 2023, Maat Pharma SA's Operating Income amounts to -19.9m EUR.

What is Maat Pharma SA's Operating Income growth rate?
Operating Income CAGR 5Y
-35%

Over the last year, the Operating Income growth was -47%. The average annual Operating Income growth rates for Maat Pharma SA have been -56% over the past three years , -35% over the past five years .

Back to Top